β-endorphin decreases fatigue and increases glucose uptake independently in normal and dystrophic mice

Muscle and Nerve

Volumn 31, Issue 4, 2005, Pages 481-486

  Khan, Salim ^a   Evans, Anthony A L ^a   Hughes, Sharon ^a   Smith, Margaret E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

endorphin; Glucose uptake; Muscle tension; Muscular dystrophy; POMC peptides

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; BETA ENDORPHIN DERIVATIVE; CARBON 14; DEOXYGLUCOSE; GLUCOSE; INSULIN; PYRUVIC ACID; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; GLUCOSE TRANSPORT; HEMIDIAPHRAGM; IMMUNOCYTOCHEMISTRY; MALE; MOTOR NERVE; MOUSE; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FUNCTION; MUSCLE TONE; MUSCULAR DYSTROPHY; NERVE ENDING; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; BETA-ENDORPHIN; DIAPHRAGM; FEMALE; GLUCOSE; MALE; MICE; MICE, INBRED C57BL; MUSCLE FATIGUE; MUSCULAR DYSTROPHY, ANIMAL;

EID: 15344340788     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20286     Document Type: Article

References (26)

1. Davies DA, Smith ME. ACTH (4-10) increases quantal content at the mouse neuromuscular junction. Brain Res 1994;637:328-330.
2. Evans AAL, Smith ME. Distribution of opioid peptide receptors in muscles of lean and obese-diabetic mice. Peptides 1996;17:629-634.
3. Evans AAL, Smith ME. Effect of β-endorphin C-terminal peptides on glucose uptake in isolated skeletal muscles of the mouse. Peptides 1997;18:165-167.
4. Evans AAL, Smith ME. Opioid receptors in fast and slow skeletal muscles of normal and dystrophic mice. Neurosci Lett 2004;366:339-341.
5. Evans AAL, Khan S, Smith ME. Evidence for a hormonal action of β-endorphin to increase glucose uptake in resting and contracting skeletal muscle. J Endocrinol 1997;155:387-392.
6. Evans AAL, Tunnicliffe G, Knights P, Bailey CJ, Smith ME. Delta opioid receptors mediate glucose uptake in skeletal muscles of lean and obese-diabetic (ob/ob) mice. Metabolism 2001;50:1402-1408.
7. Friedenberg GR, Olefsky JM. Dissociation of insulin resistance and decreased insulin receptor binding in Duchenne muscular dystrophy. J Clin Endocrinol Metab 1985;60:320-327.
8. Fulco CS, Rock PB, Muza SR, Lammi E, Braun B, Cymerman A, et al. Gender alters impact of hypobaric hypoxia on adductor pollicis muscle performance. J Appl Physiol 2001;91:100-109.
9. Fukuyama Y, Osawa M, Suzuki H. Progressive muscular dystrophy of the Fukuyama type: clinical, genetic and pathological considerations. Brain Dev 1981;13:1-29.
10. Gianoulakis C, Gupta A. Inbred strains of mice with variable sensitivity to ethanol exhibit differences in the content and processing of β-endorphin. Life Sci 1986;39:2315-2325.
11. Haynes LW, Smith ME. The actions of proopiomelanocortin peptides at the developing neuromuscular junction. Trends Pharmacol Sci 1984;5:165-168.
12. Haynes LW, Smith ME. Presence of immunoreactive α-melanotropin and β-endorphin in spinal motoneurones of the dystrophic mouse. Neurosci Lett 1985;58:13-18.
13. Haynes LW, Harborne AJ, Smith ME. Augmentation of acetylcholine response in denervated skeletal muscles by endorphins and spinal cord-conditioned culture media. Eur J Pharmacol 1983;86:415-425.
14. Hughes S, Smith ME. Pro-opiomelanocortin-derived peptides in transected and contralateral motor nerves of the rat. J Chem Neuroanat 1989;2:227-237.
15. Hughes S, Smith ME. Opioid receptors in skeletal muscle of normal and dystrophic mice. Neurosci Lett 1990;116:29-33.
16. Hughes S, Smith ME. Upregulation of the pro-opiomelanocortin gene in spinal motoneurones in muscular dystrophy in mice. Neurosci Lett 1993;163:205-207.
17. Hughes S, Shiner RA, Smith ME. Chronic stimulation of the peroneal nerve in rats upregulates the pro-opiomelanocortin gene in spinal motoneurones. Brain Res 2000;887:191-193.
18. Johnston MF, Kravitz EA, Meiri H, Rahamimoff R. Adrenocorticotrophic hormone causes long lasting potentiation of transmitter release at the neuromuscular junction. Science 1983;220:1071-1072.
19. Khan S, Smith ME. Effect of β-endorphin on the contractile responses in mouse skeletal muscle. Muscle Nerve 1995;18:1250-1256.
20. Khan S, Smith ME. Actions of β-endorphin peptides on the contractions of mouse skeletal muscle. Peptides 1997;18:87-92.
21. Lundquist I, Harris JB. Insulin secretion and carbohydrate metabolism in the dystrophic mouse. Eur J Pharmacol 1979;53:365-373.
22. Moxley RT, Griggs RC, Forbes GB, Goldblatt D, Donohoe K. Influence of muscle wasting on oral glucose tolerance testing. Clin Sci 1983;64:601-609.
23. Pestronk A, Drachman DB. A new stain for quantitative measurement of sprouting at neuromuscular junctions. Muscle Nerve 1978;1:70-74.
24. Sowell MO, Robinson KA, Buse MG. Phenyl arsine oxide and denervation effects on hormone-stimulate glucose transport. Am J Physiol 1988;255:E159-E165.
25. Strand FL, Lee SJ, Lee TS, Zuccarelli LA, Antonowich FJ, Kume J, et al. Non-corticotrophic ACTH peptides modulate nerve development and regeneration. Rev Neurosci 1993;4:321-364.
26. Xu H, Christmas P, Wu X-R, Wewer UM, Engvall E. Defective basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Nat Acad Sci USA 1994;91:5572-5576.